Patients at the James Graham Brown Cancer Center are often among the first in the world to have access to promising new therapies through leading-edge clinical trials.
Key initiatives have been developed to increase the number of clinical trials available to patients, to raise the percentage of patients participating in clinical trials, and to ensure that clinical trials are available in all the clinics. Learn more about clinical trials.
6 matches found
- 08.0452Procedures and Outcomes in Breast Cancer Detection, Treatment and Diagnosis: A Data Collection Study (Study # BCC-SURG-08-0452)
- 12.0404A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
- 09.0287 A randomized Phase III study of Conventional Whole Breast Irradiation (WBI) versus Partial Breast Irradiation (PBI) for Women with stage 0, I, or II Breast Cancer (Study # RTOG-0413 / NSABP B-39)
- 12.0289Estimating the Adherence Rate of a Monthly Bubble Package Among Women Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors (Study Number BCC-BRE-12- Adherence)
- 12.0222PRESENT: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax(tm) Treatment (Study Number PH3-01 - PRESENT)
- 10.0584A Phase II Study of Accelerated Hypofractionated Radiotherapy (AHF-RT) after Breast Conserving Surgery (BCS) in Medically Underserved Patients (Study # BCC-AHF-RT-10)
- Previous Page
- Next Page